- Home
- RFIL vs ICCC Comparison
RFIL vs ICCC Comparison
Compare RFIL & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- ICCC
- Stock Information
- Founded
- RFIL 1979
- ICCC 1982
- Country
- RFIL United States
- ICCC United States
- Employees
- RFIL N/A
- ICCC N/A
- Industry
- RFIL Electrical Products
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- ICCC Health Care
- Exchange
- RFIL Nasdaq
- ICCC Nasdaq
- Market Cap
- RFIL 43.0M
- ICCC 28.7M
- IPO Year
- RFIL N/A
- ICCC 1987
- Fundamental
- Price
- RFIL $4.07
- ICCC $3.61
- Analyst Decision
- RFIL Strong Buy
- ICCC
- Analyst Count
- RFIL 1
- ICCC 0
- Target Price
- RFIL $4.50
- ICCC N/A
- AVG Volume (30 Days)
- RFIL 17.1K
- ICCC 20.1K
- Earning Date
- RFIL 09-16-2024
- ICCC 11-13-2024
- Dividend Yield
- RFIL N/A
- ICCC N/A
- EPS Growth
- RFIL N/A
- ICCC N/A
- EPS
- RFIL N/A
- ICCC N/A
- Revenue
- RFIL $62,278,000.00
- ICCC $23,222,929.00
- Revenue This Year
- RFIL N/A
- ICCC N/A
- Revenue Next Year
- RFIL $8.38
- ICCC N/A
- P/E Ratio
- RFIL N/A
- ICCC N/A
- Revenue Growth
- RFIL N/A
- ICCC 48.05
- 52 Week Low
- RFIL $2.51
- ICCC $3.34
- 52 Week High
- RFIL $4.65
- ICCC $5.59
- Technical
- Relative Strength Index (RSI)
- RFIL 53.18
- ICCC 47.88
- Support Level
- RFIL $4.02
- ICCC $3.55
- Resistance Level
- RFIL $4.14
- ICCC $3.74
- Average True Range (ATR)
- RFIL 0.13
- ICCC 0.17
- MACD
- RFIL -0.00
- ICCC 0.00
- Stochastic Oscillator
- RFIL 56.10
- ICCC 32.88
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.